HSDT
NASDAQ
$1.81
Helius Medical Technologies Inc - Class A (HSDT)
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing and acquiring non-invasive technologies for the treatment of symptoms caused by neurological diseases or trauma. The company is headquartered in Newtown, Pennsylvania.
Sector:
Financial Services
Industry:
Asset Management
Strong Buy
Target: $3.50 (+93.37%)
Market Cap
$95M
P/B Ratio
0.50
Revenue 5Y CAGR
+50.33%
Free Cash Flow Yield
-18.84%
Price Chart
Valuation
Market Cap$95M
P/S10.66
P/B0.50
Profitability
Total Revenue (TTM)$4.13M
Gross Profit (TTM)$9.03M
EBITDA-$137M
Operating Margin-2751%
EPS-$0.93
Financial Health
Free Cash Flow Yield-18.84%
Growth & Risk
Revenue 5Y CAGR+50.33%
FCF 5Y CAGR+10.14%
Sharpe Ratio-0.17